| Patent application number | Description | Published |
|---|
| 20090154200 | CONTROLLER CIRCUIT AND SYSTEM HAVING SUCH A CONTROLLER CIRCUIT - A controller circuit is specified, having a step-up controller, a resonant converter connected downstream of the step-up controller on the output side, a transformer, a rectifier, which rectifier is connected to the secondary winding of the transformer on the input side, and a CLL resonant circuit connected to the resonant converter and to the primary winding of the transformer, which CLL resonant circuit has a resonance capacitance and a first and a second resonance inductance. In order to reduce the switching losses, the CLL resonant circuit is embodied as a “T” circuit. | 06-18-2009 |
| 20090316443 | AC/DC INTERMEDIATE-CIRCUIT CONVERTER HAVING A VERY WIDE AC INPUT VOLTAGE RANGE - An AC/DC intermediate-circuit converter has a very wide AC input voltage range with a ZVS three-level DC/DC resonant converter with an LLC series-resonant circuit. Two intermediate-circuit capacitors are connected in series between DC intermediate-circuit connections with their common connection point forming a DC intermediate-circuit centre connection ( | 12-24-2009 |
| 20110103118 | NON-ISOLATED DC-DC CONVERTER ASSEMBLY - A non-isolated DC-DC converter assembly includes a boost converter and a Ćuk converter connected together in a specific way. The non-isolated DC-DC converter assembly allows for grounding of a source and load at the same time, and provides a complete adjustability of the output voltage of the non-isolated DC-DC converter. Further, the DC-DC converter assembly of the disclosure has a current source input characteristic, whereby the current absorbed from the power supply is continuous | 05-05-2011 |
| 20110221420 | CONTROL METHOD FOR SINGLE-PHASE GRID-CONNECTED LCL INVERTER - A method of controlling the grid-side current of a single-phase grid-connected converter having an LCL filter connected between the output of the converter and the grid. The method includes measuring a grid voltage (v | 09-15-2011 |
| 20110222317 | CONVERTER CIRCUIT AND UNIT AND SYSTEM COMPRISING SUCH CONVERTER CIRCUIT - A converter circuit has a first resonant converter that is connected on the DC voltage side to a first energy storage circuit, and a transformer. A second resonant converter is connected on the AC voltage side to the secondary winding of the transformer and on the DC voltage side to a load converter, and a CLL resonant circuit is connected to the first resonant converter and to the primary winding of the transformer. The CLL resonant circuit has a resonant capacitance, a first resonant inductance and a second resonant inductance. | 09-15-2011 |
| 20110228578 | NON-ISOLATED DC-DC CONVERTER FOR SOLAR POWER PLANT - An exemplary non-isolated DC-DC converter for a solar power plant, can be adapted to connect to a full-bridge inverter. The converter includes positive and negative input terminals, and positive and negative output terminals. A plurality of switches, diodes, inductors and capacitors are connected in a circuit configuration to the input and output terminals. A control means is connected to the circuit for controlling the switching of a first, second, and third switch between an open and closed state. | 09-22-2011 |
| Patent application number | Description | Published |
|---|
| 20090028872 | HUMAN MONOCLONAL ANTIBODIES TO CD70 - The present disclosure provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to CD70 with high affinity. Nucleic acid molecules encoding the antibodies of the disclosure, expression vectors, host cells and methods for expressing the antibodies of the disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the disclosure are also provided. The disclosure also provides methods for treating cancer, autoimmune disease, inflammation and viral infections. | 01-29-2009 |
| 20100150950 | HUMAN ANTIBODIES THAT BIND CD70 AND USES THEREOF - The present disclosure provides isolated monoclonal antibodies that specifically bind to CD70 with high affinity, particularly human monoclonal antibodies. Preferably, the antibodies bind human CD70. In certain embodiments, the antibodies are capable of being internalized into CD70-expressing cells or are capable of mediating antigen dependent cellular cytotoxicity. Nucleic acid molecules encoding the antibodies of this disclosure, expression vectors, host cells and methods for expressing the antibodies of this disclosure are also provided. Antibody-partner molecule conjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of this disclosure are also provided. This disclosure also provides methods for detecting CD70, as well as methods for treating cancers, such as renal cancer and lymphomas, using an anti-CD7Q antibody of this disclosure. | 06-17-2010 |
